Načítá se...

Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions

For nearly 30 years, patients with transfusional iron overload have depended on nightly deferoxamine infusions for iron chelation. Despite dramatic gains in life expectancy in the deferoxamine era for patients with transfusion-dependent anemias, the leading cause of death for young adults with thala...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Neufeld, Ellis J.
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society of Hematology 2006
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895765/
https://ncbi.nlm.nih.gov/pubmed/16627763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-02-002394
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!